Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Abate, Dereje ^a,b   Taye, Bineyam ^a   Abseno, Mohammed ^b   Biadgilign, Sibhatu ^c  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b St Peter Specialized TB Hospital   (Ethiopia)

^c JIMMA UNIVERSITY   (Ethiopia)

Author keywords

Drug resistance; Drug susceptibility; Epidemiology; MDR TB; Trend

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; DRUG EFFECT; ETHIOPIA; FEMALE; HOSPITAL; HUMAN; MALE; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; ETHIOPIA; FEMALE; HOSPITALS, SPECIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865330003     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-462     Document Type: Article

References (27)

1. WHO, World Health Organization: Global Tuberculosis control: Surveillance, planning and Financing 2008 http://www.who.int/tb/publications/ global-report/en/ ] website WHO report
2. WHO, World Health Organization: Global tuberculosis control: WHO report 2011 2011 http://www.who.int/about/licensing/copyright-form/en/index.html). WHO report
3. Human Immunodeficiency virus (HIV) infection in tuberculosis patients in Addis Ababa. Demissie MLB, Tegbaru B, Ethiop J Health Dev 2000 14 277 282
4. Federal Ministry of Health, Guideline for program and Clinical Management of drug Resistant Tuberculosis Ethiopia: FMOH, Addis Ababa 1 2009
5. WHO, Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response 2010
6. Extensively drug resistant tuberculosis. Wilkinson LSR, BMJ 2006 333 7568 559 560 10.1136/bmj.38971.587222.AB 16973988
7. Tuberculosis 2007 from basic science to patient care. Juan C, Palomino SC, Viviana R, 2007 635 636
8. Addressing the threat of tuberculosis caused by extensively drug-resistant Mycobacterium tuberculosis. WHO: World Health Organization, Wkly Epidemiol Rec 2006 81 386 390 17042081
9. Assessment of world-wide tuberculosis control. Raviglione MC DC, Schmidt S, Kochi A, Lancet 1997 350 624 629 10.1016/S0140-6736(97)04146-9 9288045
10. Ethiopian Health and Nutrition Research Institute, TB Laboratory Standard Operating Procedure (SOP) Addis Ababa, Ethiopia: EHNRI 2007 Unpublished document
11. Iseman M, A clinician's guide to tuberculosis Philadelphia: Lippincott-Williams and Wilkins 2000 323 353 23175499
12. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter. Meskel DW AG, Lakew M, et al. Tubercul Specialized Hosp Ethiop Med J 2008 46 3 219 225
13. Prevalence of drug resistant tuberculosis in Arsi Zone. Mekdes Gebeyehu EL, Getachew E, Ethiop Ethiop J Health Dev 2001 15 11 16
14. Drug susceptibility of Mycobacterium tuberculosis isolatesfrom smears negative pulmonary tuberculosis patients, Addis Ababa, Ethiopia. Kassu Desta DA, Eshetu L, Mekdes G, Beniam F, Ethiop J Health Dev 2008 22 2 212 215
15. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiop. Demissie MGM, Berhane Y, Int J Tuberc Lung Dis 1997 1 1 64 67 9441061
16. Molecular Epidemiology and Drug Resistance of Mycobacterium tuberculosis Isolates from Ethiopian Pulmonary Tuberculosis Patients with and without Human Immunodeficiency Virus Infection. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S, Lindquist L, J Clin Microbiol 2002 40 5 1636 1643 10.1128/JCM.40.5.1636-1643.2002 11980933
17. Results from 8 years of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Thomsen V BJ, Lillebaek T, Glisman S, Eur Respir J 2000 16 203 208 10.1183/09031936.00.16220300 10968492
18. Drug resistance of Mycobacterium tuberculosis in Western Turkey: a retrospective study from 1100-bed teaching hospital. Senol GKB, Komurcuoglu A, J Infect 2005 50 4 306 311 10.1016/j.jinf.2004.05.010 15845428
19. Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis. Kart L, Remzi A, Tor M, Gulmez I, Oymak SF, Atmaca HM, Erdem F, Ann Clin Microbiol Antimicrob 2002 1 6 10.1186/1476-0711-1-6 12537590
20. Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Gupta PR, Singhal B, Sharma PN, Gupta RB, Ind J Med Res 1993 97 102 103
21. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. JA A-MA A-Tq, Abed MS, Chest 2005 128 3229 3232 10.1378/chest.128.5.3229 16304266
22. Global surveillance for anti-tuberculosis drug resistance,19941997. Pablos Mendez ARM, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. N Engl J Med 1998 338 1641 1649 10.1056/NEJM199806043382301 9614254
23. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. O'Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N, Emerg Infect Dis 2011 17 10 1942 1945 10.3201/eid1710.110105 22000378
24. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Faustini AHA, Perucci CA, Thorax 2006 61 158 163 10.1136/thx.2005. 045963 16254056
25. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Law WS YW, Chiu C, Kam KM, Tam CM, Chan CK, Leung CC, Int J Tuberc Lung Dis 2008 12 1065 1070 18713506
26. Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead. XW SYYD, Lu W, Song H, Dai Y, Shen H, Wang J, BMC Public Health 2011 11 110 10.1186/1471-2458-11-110 21324205
27. Tuberculosis control program Resolution WHA44.8. Forty-fourth World Health Assembly. WHO, Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. Volume III, 3rd edition (1985-1992) Geneva: WHO; WHO document WHA44/1991/REC/1 1993